Sort
35,931 grants matching “parkinsons”
Cell Type and Regional Vulnerability in Frontotemporal Dementia
$2,094,351Sally Temple · Regenerative Research Foundation · RF1 · FY2021 · NS
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,093,857Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Modulation Of Neuronal Channels and Receptors in the Brain
$2,093,404Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Dementia with Lewy Bodies Consortium
$2,091,032James Bruce Leverenz · Cleveland Clinic Lerner Com-Cwru · U01 · FY2022 · NS
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,089,144Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Traumatic Brain Injury and Repetitive Head Impacts: Contributions to AD/ADRD and CTE Neuropathology and Resulting Clinical Syndromes
$2,086,962Ann Carolyn McKee · Boston University Medical Campus · U54 · FY2019 · NS
Neuroprotection Studies in PD: A Coordinating Center
$2,085,990Karl D. Kieburtz · University Of Rochester · U01 · FY2007 · NS
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
$2,085,362Brian Jason Wainger · Massachusetts General Hospital · RF1 · FY2023 · NS
Modulation Of Neuronal Channels and Receptors in the Brain
$2,084,890Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
Mechanisms of dopamine neuron degeneration
$2,083,418Robert E Burke · Columbia University Health Sciences · P50 · FY2011 · NS
S-Nitrosylation-Dependent Pathological Spread of Abnormal Proteins in Frontotemporal Dementia and Lewy Body Dementia
$2,081,944Tomohiro Nakamura · Scripps Research Institute, The · RF1 · FY2021 · NS
CAFFEINE, ADENOSINE RECEPTORS AND ESTROGEN IN TOXIN MODELS OF PARKINSON'S DISEASE
$2,080,248The General Hospital Corporation · · FY2008 · Department of the Army
Novel Therapeutic Approaches for Parkinson's Disease
$2,078,654Ole Isacson · Mclean Hospital · P50 · FY2009 · NS
Differential diagnosis of Parkinson's and multiple system atrophy in non-human primate models using a novel a-synuclein retinal contrast agent and AI-assisted analytics
$2,077,573Stella Sarraf · Amydis Diagnostics, Inc. · R44 · FY2021 · NS
Molecular signaling during development and maturation of the nervous system
$2,073,197David Talmage · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
Harnessing Movement Variability to Treat and Prevent Motor Related Disorders
$2,070,473Nick Stergiou · University Of Nebraska Omaha · P20 · FY2021 · GM
Decoding the BETA-arrestin2-LMBRD2 cascade in ALPHA-synuclein pathogenesis.
$2,069,215Junga "alexa" Woo · Case Western Reserve University · RF1 · FY2024 · NS
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,069,209Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Central Nervous System Drug Delivery Techniques
$2,068,109Russell Lonser · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
Laboratory of Molecular Imaging and Nanomedicine
$2,067,417Xiaoyuan Chen · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2010 · EB
"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"
$2,067,401Ellen Sidransky · National Human Genome Research Institute · Z01 · FY2008 · HG
Functional and Pharmacological Significance of Receptor Heteromers in the CNS
$2,065,937Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2015 · DA
Modulation Of Neuronal Channels and Receptors in the Brain
$2,064,429Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES
Leucine rich repeat kinase 2 and dominantly inherited Parkinson disease
$2,063,044Mark Cookson · National Institute On Aging · ZIA · FY2025 · AG
Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration
$2,062,691Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2023 · DA